Firestormm
Senior Member
- Messages
- 5,055
- Location
- Cornwall England
20 August 2013
Association Announces its New Research Advisory Council
In 2011, The CFIDS Association brought together a group of leaders in the field of ME/CFS to help direct our research efforts. Recently we invited additional members to our Research Advisory Council (formerly called the Scientific Advisory Board). The Research Advisory Council will help guide and shape our research road-map and regulatory framework for ME/CFS. We are honored to have the benefit of diverse expertise from these esteemed experts representing a variety of scientific and strategic disciplines.
The backgrounds and qualifications of our advisors help ensure the strength of our program:
Italo Biaggioni, M.D.
Professor of Medicine, Professor of Pharmacology, Vanderbilt University
Gordon Broderick, Ph.D.
Professor, Center for Psychological Studies, Nova Southeastern University
Russell “Rusty” Bromley
Principal, TRAC Consulting
Paul R. DeStefano, J.D.
Partner, McDermott Will & Emery LLP
Roger Y. Dodd, Ph.D.
Vice President, Research and Development and Director, American Red Cross, Holland Laboratory
Mark A. Demitrack, M.D.
Vice President and Chief Medical Officer, Neuronetics, Inc.
K. Kimberly McCleary
Patient-Centered Research Advocate and Consultant
Kelly Morren, B.S.
Global Director, ServiceSource International
Bernard Munos
Principal, InnoThink
Peter C. Rowe, MD
Professor of Pediatrics, Johns Hopkins Children’s Center
Tomasz Sablinski, M.D., Ph.D.
Founder and CEO, Transparency Life Sciences; Managing Director, Auven Therapeutics
Terry Tyler, M.D.
Diagnostic Radiologist
For full profiles hit the link here or in the title.
I am not certain in what direction this line-up of research advisors implies CFIDS are moving. I need to read the profiles more closely...